Stock Price
1.71
Daily Change
-0.06 -3.13%
Monthly
22.66%
Yearly
-6.32%
Q1 Forecast
1.64

Autolus Therapeutics Ltd reported $22.61M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AstraZeneca USD 15.5B 313M Dec/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Silence Therapeutics USD 159K 983K Mar/2025